Back to Search
Start Over
AB928, a dual antagonist of the A 2a R and A 2b R adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy
- Source :
- European Journal of Cancer. 92:S14-S15
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
Details
- ISSN :
- 09598049
- Volume :
- 92
- Database :
- OpenAIRE
- Journal :
- European Journal of Cancer
- Accession number :
- edsair.doi...........26c5f7f382034270c4f93f001708099b
- Full Text :
- https://doi.org/10.1016/j.ejca.2018.01.037